Novel Integration of New prostate radiation therapy schedules with adJuvant Androgen deprivation

In men with intermediate and high-risk prostate cancer, the NINJA trial is looking at comparing two different radiotherapy treatment schedules called stereotactic body radiotherapy (SBRT). The aim is to develop better methods of treatment for prostate cancer using this type of treatment, and further understand what causes some of the side effects of treatments. It is hoped this research will potentially improve the accuracy and quality of radiotherapy treatment in prostate cancer.

Primary Sponsor

Trans Tasman Radiation Oncology Group (TROG)

Collaborating Groups

Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)

Participating Centres

Accrual Target

472

Final Accrual

472

Current Accrual

Closing Date of Accrual

14 July 2026

Trial Chairperson

Prof Jarad Martin, Calvary Mater Hospital, NSW, Australia

Dr Mark Sidhom, Liverpool Hospital, NSW, Australia

Trial Contact

chc-calvarymater-ninjatrial@health.nsw.gov.au

Clinical Trial Registration

Related Post

new TROG Scientific Committee Chair Elect and members
21 July, 2026

New TROG Scientific Committee Chair-Elect and members bring diverse experience

LATEST NEWS: 21 July 2026 The TROG Scientific Committee

RAVES sub-study publication
16 July, 2026

TROG 08.03 RAVES sub-study sheds light on quality of life after post-prostatectomy radiotherapy

LATEST NEWS: 16 July 2026 Secondary analysis of data